<DOC>
	<DOCNO>NCT00403533</DOCNO>
	<brief_summary>We hypothesize atorvastatin decrease HCV viral load patient take medication . Cholesterol need HCV virion production . Cell culture study show atorvastatin ( HMG-CoA reductase inhibitor ) decrease HCV viral replication . As atorvastatin proven decrease heart attack stroke patient high cholesterol , medication indicate treatment elevate cholesterol risk individual . Therefore propose study effect atorvastatin viral load patient initiate atorvastatin therapy elevate cholesterol .</brief_summary>
	<brief_title>Assessment Antiviral Effect Atorvastatin Hepatitis C Virus</brief_title>
	<detailed_description>Men woman age 30 80 infected HCV viremia whose physician determine need cholesterol lower medication recruit study investigator Massachusetts General Hospital . The study investigator approach potential subject refer doctor ascertain potential subject interested meeting investigator . Each subject consent undergo phlebotomy 10 cc blood three time . Once prior initiation atorvastatin measure patient viral load . In addition , patient undergo phlebotomy 4 12 week initiation atorvastatin . The week 12 phlebotomy require patient start atorvastatin monitor side effect . Therefore patient enroll study undergo one additional phlebotomy . As part study extra 10 cc blood take time measure patient HCV viral load .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Antiviral Agents</mesh_term>
	<criteria>Patients chronic HCV . Patients need treatment elevate cholesterol : Total cholesterol &gt; 240 LDL &gt; 160 without cardiac risk factor LDL &gt; 130 two cardiac risk factor ( hypertension , smoker , family history heart attach , HDL &lt; 40 men &lt; 50 woman ) LDL &gt; 100 diabetes know coronary artery disease Impaired mental ability prevent subject understanding protocol complete entire study . HCC A history adverse reaction HMG CoA reductase inhibitor . Patients HCV treatment , plan initiate HCV treatment within 3 month , discontinue HCV treatment within last 3 month . Patients whose aminotransferase &gt; 5 time upper limit normal .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2006</verification_date>
	<keyword>Hepatitis C</keyword>
	<keyword>viral load</keyword>
	<keyword>antiviral therapy</keyword>
	<keyword>cholesterol</keyword>
	<keyword>atorvastatin</keyword>
</DOC>